Stiff man-like syndrome and generalized myokymia in spinocerebellar ataxia type 3

Movement Disorders

Volumn 21, Issue 7, 2006, Pages 1031-1035

  Berciano, José ^a   Infante, Jon ^a   García, Antonio ^a   de Pablos, Carmen ^a   Amer, Guillermo ^a   Polo, José Miguel ^b   Vopini, Victor ^c   Combarros, Onofre ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c Duran i Reynals Hospital   (Spain)

Author keywords

Dysautonomia; Facial action myoclonus; Machado Joseph disease; Myokymia; Spinocerebellar ataxia type 3; Stiff man syndrome

Indexed keywords

ADENINE; CYTOSINE; GUANINE;

ADULT; ALLELE; ARTICLE; CASE REPORT; CEREBELLAR ATAXIA; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ELECTROPHYSIOLOGY; GENE MUTATION; HUMAN; MACHADO JOSEPH DISEASE; MALE; MOTOR UNIT; MUSCLE CONTRACTION; MYOKYMIA; ONSET AGE; OPHTHALMOPLEGIA; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; PYRAMIDAL SIGN; STIFF MAN SYNDROME; SYMPTOM; TRINUCLEOTIDE REPEAT;

ADULT; AGED; ALLELES; ATROPHY; BRAIN STEM; CEREBELLUM; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; MACHADO-JOSEPH DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOKYMIA; NERVE TISSUE PROTEINS; NEUROLOGIC EXAMINATION; NUCLEAR PROTEINS; OPHTHALMOPLEGIA; PEDIGREE; PHENOTYPE; REPRESSOR PROTEINS; STIFF-PERSON SYNDROME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33746873251     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20865     Document Type: Article

References (36)

1. Lima L, Coutinho P. Clinical criteria for diagnosis of Machado-Joseph disease: report of non-Azorean Portuguese family. Neurology 1980;30:319-322.
2. Sequeiros J, Coutinho P. Epidemiology and clinical aspects of Machado-Joseph disease. Adv Neurol 1993;61:139-153.
3. Cancel G, Abbas N, Stevanin G, et al. Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus. Am J Hum Genet 1995;57:809-816.
4. Matilla T, McCall A, Subramony SH, et al. Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease. Ann Neurol 1995;38:68-72.
5. Silveira I, Lopes-Cendes I, Kish S, et al. Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients. Neurology 1996;46:214-218.
6. Higgins JJ, Nee LE, Vasconcelos O, et al. Mutations in American families with spinocerebellar ataxia (SCA) type 3: SCA3 is allelic to Machado-Joseph disease. Neurology 1996;46:208-213.
7. Dürr A, Stevanin G, Cancel G, et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular and neuropathological features. Ann Neurol 1996;39:490-499.
8. Watanabe M, Abe K, Aoki M, et al. Analysis of CAG trinucleotide expansion associated with Machado-Joseph disease. J Neurol Sci 1996;136:101-107.
9. Schöls L, Amoiridis G, Epplen JT, et al. Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation. J Neurol Neurosurg Psychiatry 1996;61:466-470.
10. Maruyama H, Kawakami H, Khoriyama T, et al. CAG repeat length and disease duration in Machado-Joseph disease: a new clinical classification. J Neurol Sci 1997;152:166-171.
11. Soong B, Cheng C, Liu R, et al. Machado-Joseph disease: clinical, molecular, and metabolic characterization in Chinese kindreds. Ann Neurol 1997;41:446-452.
12. n. Arch Neurol 2001;58:899-904.
13. Coutinho P, Guimarães A, Scaravilli F. The pathology of Machado-Joseph disease: report of a possible homozygous case. Acta Neuropathol (Berl) 1982;58:48-54.
14. Coutinho P, Guimarães A, Melo Pires M, et al. The peripheral neuropathy in Machado-Joseph disease. Acta Neuropathol (Berl) 1986;71:119-124.
15. Tsuchiya K, Wakabayashi M, Oyanagi S, et al. Machado-Joseph disease in Japan: clinicopathological study of 6 autopsy cases with special reference to the clinicopathological correlation to cerebellar ataxia and lower motor neuron signs. Neuropathology 1994;14:13-36.
16. Robitaille Y, Schut L, Kish SJ. Structural and immunocytochemical features of olivopontocerebellar atrophy caused by spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype. Acta Neuropathol 1995;90:572-581.
17. Schöls L, Bauer P, Schmidt T, et al. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3:291-304.
18. Infante J, Combarros O, Volpini V, et al. Autosomal dominant cerebellar ataxias in Spain: molecular and clinical correlations, prevalence estimation and survival analysis. Acta Neurol Scand 2005;111:391-399.
19. Auger RG. Diseases associated with excess motor unit activity. Muscle Nerve 1994;11:1250-1263.
20. Barker RA, Revesz T, Thom M, et al. Review of 23 patients affected of the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 1998; 65:633-640.
21. Meinck HM, Thompson PD. Stiff man syndrome and related disorders. Mov Disord 2002;17:853-866.
22. Schöls L, Amoiridis G, Büttner T, et al. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined phenotypes? Ann Neurol 1997;42:924-932.
23. Gutmann L, Gutmann L. Myokymia and neuromyotonia 2004. J Neurol 2004;251:138-142.
24. Valls-Solé J, Montero J. Role of EMG evaluation in muscle hyperactivity syndromes. J Neurol 2004;251:251-260.
25. Coutinho P, Andrade C. Autosomal dominant system degeneration in Portuguese families of the Azores Islands: a new genetic disorder involving, cerebellar, pyramidal and spinal cord motor functions. Neurology 1978;28:703-709.
26. Rosenberg RN, Nyhan WL, Coutinho P, et al. Joseph's disease: an autosomal dominant neurological disease in the Portuguese of the United States and of Azores Islands. Adv Neurol 1978;21:33-57.
27. Berciano J. Olivopontocerebellar atrophy: a review of 117 cases. J Neurol Sci 1982;53:253-272.
28. Sakajiri K, Makifuchi T, Fukuhara N, et al. Quantitative study of intermediolateral cell counts in Machado-Joseph disease. J Neurol Sci 1996;144:156-159.
29. Terao S, Sobue G, Hashizume Y, et al. Disease-specific patterns of neuronal loss in the spinal ventral horn in amyotrophic lateral sclerosis, multiple system atrophy and X-linked recessive bulbospinal neuronopathy, with special reference to the loss of small neurons in the intermediate zone. J Neurol 1994;241:196-203.
30. Lou JS, Valls-Solé J, Toro C, et al. Facial action myoclonus in patients with olivopontocerebellar atrophy. Mov Disord 1994;9: 223-226.
31. Valls-Solé J, Lou JS, Hallett M. Brainstem reflexes in patients with olivopontocerebellar atrophy. Muscle Nerve 1994;17:1439-1448.
32. Blunt SB, Khalil NM, Perkin GD. Facial myokymia in multiple system atrophy. Mov Disord 1997;12:235-238.
33. Rosenberg RN. Machado-Joseph disease: an autosomal dominant motor system degeneration. Mov Disord 1992;7:193-203.
34. Kanai K, Kubawara S, Arai K, et al. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain 2003;126:965-973.
35. Klockgether T, Schöls L, Abele M, et al. Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/ MJD). J Neurol Neurosurg Psychiatry 1999;66:222-224.
36. Yeh TH, Lu CS, Wu YH, et al. Autonomic dysfunction in Machado-Joseph disease. Arch Neurol 2005;62:630-630.